Global biosimilars manufacturer scaling production and regulatory operations across developed markets
Biocon Biologics operates a manufacturing-and-regulatory-heavy organization with six approved biosimilar molecules now marketed in the US, EU, Australia, Canada, and Japan. The tech stack is dominated by SAP (IBP, ECC, S/4HANA) for supply-chain and enterprise planning, paired with lab infrastructure (HPLC, UPLC, LIMS, Chromeleon) and industrial automation (Siemens PLC, Rockwell). Hiring is concentrated in sales and ops roles across 12 countries, with active projects spanning regulatory dossier preparation, supply-chain IBP implementation, and GMP validation — indicating heavy investment in scaling manufacturing footprint and compliance infrastructure to support global market expansion.
Notable leadership hires: Commercial Team Lead, Validation Lead, Medical Affairs Head, National Account Director, Sales Lead
Biocon Biologics is a subsidiary of Biocon Limited focused on developing and manufacturing biosimilar therapeutics for diabetes, oncology, immunology, and other chronic diseases. The company employs approximately 4,800 people and operates as a fully integrated global organization with approved products in regulated markets including the United States, European Union, Australia, Canada, and Japan. Manufacturing capabilities span drug substance production, testing, and quality assurance, supported by enterprise resource planning and laboratory information systems. The business model targets cost reduction and patient access while maintaining compliance across multiple regional regulatory frameworks.
Core systems include SAP (IBP, ECC, S/4HANA) for supply-chain and enterprise planning; laboratory infrastructure (HPLC, UPLC, LIMS, Chromeleon, GraphPad Prism); industrial automation (Siemens PLC, Rockwell Automation, Cognex vision); and Microsoft Office, Azure, and Figma for standard productivity and design.
Bengaluru, Karnataka, India. Founded in 1978 as part of Biocon Limited; operates as a global subsidiary with regulatory and manufacturing presence in multiple regions.
Other companies in the same industry, closest in size